Pharmacokinetic study of controlled release Ropinirole Hydrochloride Osmotic Pump Tablets

Wanzhi ZHANG,Xiuhua WANG,Minquan HUI,Hongmei JI,Jianwei DOU

DOI: https://doi.org/10.3969/j.issn.1004-2407.2016.02.018

2016-01-01

Abstract:Objective To establish a determination method of ropinirole hydrochloride in animal plasma to evaluate the pharmacoki‐netics of controlled release Ropinirole Hydrochloride Osmotic Pump Tablets ,and to provide the relative bioavailability compared with reference formulation (Requip XL ) Methods A single oral dose of controlled release Ropinirole Hydrochloride Osmotic Pump Tablets (test formulation) and Requip XL (reference formulation) were administered to six Beagle dogs respectively .The concentration of ropinirole hydrochloride in Beagle dog plasma was analyzed by LC‐MS .The pharmacokinetic parameters and rela‐tive bioavailability were calculated .Results The main pharmacokinetic parameters of reference formulation and tested formulation were as follows :tmax were (2 .92 ± 0 .49) and (3 .58 ± 0 .49) h ,respectively ;Cmax were (2 .60 ± 0 .41) and (2 .35 ± 0 .39) ng · mL -1 ,respectively ;MRT were (7 .76 ± 0 .89) and (8 .48 ± 0 .59) h ,respectively ;t1/2 (Ke) were (4 .70 ± 0 .67) and (5 .94 ± 1 .19) h , respectively ;AUC(0‐t) were (16 .06 ± 5 .55) and (17 .90 ± 2 .75) ng · mL -1 · h ,respectively ;AUC(0 - ∞ ) were (16 .71 ± 5 .87) and (19 .03 ± 3 .08) ng · mL -1 · h ,respectively .The relative bioavailability of the test formulation and reference formulation was 111 .48% .Conclusion The results suggested that the main pharmacokinetic parameters have no significant difference .The meth‐od established can be used to determine the concentration of ropinirole hydrochloride in plasma and to evaluate the pharmacokinet‐ics and relative bioavailability in animal studies .